Recent Finacing
Recent Raise
Navitor develops small-molecule therapeutics that selectively modulate mTORC1 signaling using a Sabatini-based discovery platform to generate up- or down-regulating candidates for metabolic, neurodegenerative, immune, musculoskeletal, rare, and age-related indications.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors